Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)

The National Cancer Institute (NCI) presents a grant opportunity titled 'Pragmatic Trials across the Cancer Control Continuum.' It requires clinical trials and intends to expedite the creation of evidence-based cancer interventions. The goal is to bolster health equity and reflect the diversity across various types of people, settings, and contexts within the United States.

This funding opportunity specifically supports research examining the impact of cancer interventions on cancer-related outcomes across all stages of cancer control. The research approach should utilize a pragmatic trial study design, which is a practical, real-world testing technique.

Funding for this project is set up through a two-step cooperative agreement mechanism labeled UG3/UH3. The UG3 phase is designed to fine-tune the cancer-related intervention and conclude all study-related tasks in readiness for the UH3 phase. The subsequent UH3 phase is intended for actual implementation of the pragmatic trial.